General Enquiries (Headquarters)
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
UK
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Pharmacovigilance
For medical information enquiries, complaints and adverse events reporting, contact:
Email: pv@hikma.com
Business Development
For all business development enquiries contact:
US and Canada: usbusinessdevelopment@hikma.com
Europe: EUBusinessDevelopment@Hikma.com
Investor Relations
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
UK
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: investors@hikma.uk.com
Commercial
For Canada, contact: canada_sales@hikma.com
For EU, contact: europe_commercial@hikma.com
For MENA, contact: customers@hikma.com
For US, contact: customerservice@hikma.com
Tel: 1.800.631.2174
Please note: if you have a question about a medical condition, please contact your doctor or a healthcare professional.
Sustainability
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
UK
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: sustainability@hikma.com
Media
Hikma Pharmaceuticals PLC
1 New Burlington Place,
London
W1S 2HR
UK
Tel: +44 (0) 20 7399 2760
Fax: +44 (0) 20 7399 2761
Email: mediainquiries@hikma.com
Shareholder information
Everything you need to manage your shares, including share listings, depositary receipts, share price information, and dividends.
Please note: if you have a question about a medical condition, you should speak to a healthcare professional.
Last reviewed on 30 May 2022